Up-regulation of kidney NAD(P)H oxidase and calcineurin in SHR: Reversal by lifelong antioxidant supplementation

Kidney International

Volumn 65, Issue 1, 2004, Pages 219-227

  Zhan, Chang De ^b   Sindhu, Ram K ^b   Vaziri, Nosratola D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

Calcineurin; Hypertension; Kidney; NAD(P)H oxidase; Oxidative stress

Indexed keywords

3 NITROTYROSINE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CALCINEURIN; CALCINEURIN A ALPHA; CALCINEURIN B; GLYCOPROTEIN GP 91; HYDROGEN PEROXIDE; MALONALDEHYDE; PROTEIN P22; PROTEIN P22PHOX; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SELENIUM; SUPEROXIDE; UNCLASSIFIED DRUG; ZINC;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT FORTIFIED DIET; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY WEIGHT; CONTROLLED STUDY; DIET; DIET MODIFICATION; DIET SUPPLEMENTATION; DISEASE MARKER; DISEASE SEVERITY; HYPERTENSION; IMMUNOREGULATION; INFLAMMATION; KIDNEY CORTEX; KIDNEY PARENCHYMA; MALE; NONHUMAN; ONSET AGE; OXIDATIVE STRESS; PRENATAL PERIOD; PRIORITY JOURNAL; RAT; RAT STRAIN; SPONTANEOUSLY HYPERTENSIVE RAT; STRAIN DIFFERENCE; UPREGULATION;

EID: 0347362495     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00372.x     Document Type: Article

References (52)

1. OKAMOTO K, AORKI K: Development of a strain of spontaneously hypertensive rats. Jpn Circ J 27:282-293, 1963
2. BERRY C, BROSNAN MJ, FENNELL J, et al: Oxidative stress and vascular damage in hypertension. Curr Opin Nephrol Hypertens 10:247-255, 2001
3. DHALLA NS, TEMSAH RM, NETTICADAN T: Role of oxidative stress in cardiovascular diseases. J Hypertens 18:655-673, 2000
4. SCHNACKENBERG CG: Physiological and pathophysiological roles of oxygen radicals in the renal microvasculature. Am J Physiol (Regulatory Physiol) 282:R335-R342, 2002
5. WILCOX CS: Reactive oxygen species: Roles in blood pressure and kidney function. Curr Hypertens Rep 4:160-166, 2002
6. BARTON CH, NI Z, VAZIRI ND: Enhanced nitric oxide inactivation in aortic coarctation-induced hypertension. Kidney Int 60:1083-1087, 2001
7. MAKINO A, SKELTON MM, ZOU AP, et al: Increased renal medullary oxidative stress produces hypertension. Hypertension 39:667-672, 2002
8. ZHOU XJ, VAZIRI ND, WANG XQ, et al: Nitric oxide synthase expression in hypertension induced by inhibition of glutathione synthase. J Pharmacol Exp Ther 300:762-767, 2002
9. VAZIRI ND, WANG XQ, OVEISI F, et al: Induction of oxidative stress by glutathione depletion causes severe hypertension in normal rats. Hypertension 36:142-146, 2000
10. VAZIRI ND, LIANG K, DING Y: Increased nitric oxide inactivation by reactive oxygen species in lead-induced hypertension. Kidney Int 56:1492-1498, 1999
11. VAZIRI ND, NI Z, OVEISI F, et al: Enhanced nitric oxide inactivation and protein nitration by reactive oxygen species in renal insufficiency. Hypertension 39:135-141, 2002
12. ROBERTS CK, VAZIRI ND, WANG XQ, et al: Enhanced NO inactivation induced by a high fat, refined-carbohydrate diet. Hypertension 36:423-429, 2000
13. EL MIDAOUI A, DE CHAMPLAIN J: Prevention of hypertension, insulin resistance, and oxidative stress by alpha-lipoicd acid. Hypertension 39:303-307, 2002
14. PARK JB, TOUYZ RM, CHEN X, et al: Chronic treatment with a superoxide dismutase mimetic prevents remodeling and progression of hypertension in salt-loaded stroke-prone spontaneously hypertensive rats. Am J Hypertens 15:78-84, 2002
15. SCHNACKENBERG CG, WELCH WJ, WILCOX CS: Normalization of blood pressure and renal vascular resistance in SHR with a membrane permeable superoxide dismutase mimetic: Role of nitric oxide. Hypertension 32:59-64, 1998
16. SCHNACKENBERG CG, WILCOX CS: Two-week administration of tempol attenuates both hypertension and renal excretion of 8-iso prostaglandin f2 alpha. Hypertension 33:424-428, 1999
17. WU R, LAMONTAGNE D, DE CHAMPLAIN J: Antioxidative properties of acetylsalicylic acid on vascular tissues from normotensive and spontaneously hypertensive rats. Circulation 105:387-392, 2002
18. NOGUCHI T, IKEDA K, SASAKI Y, et al: Effects of vitamin E and sesamin on hypertension and cerebral thrombogenesis in stroke-prone spontaneously hypertensive rats. Hypertens Res 24:735-742, 2001
19. CHEN X, TOUYZ RM, PARK JB, et al: Antioxidant effects of vitamin C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR. Hypertension 38:606-611, 2001
20. WILCOX CS, WELCH WJ: Oxidative stress: Cause or consequence of hypertension. Exp Biol Med 226:619-620, 2001
21. CABASSI A, BOUCHARD JF, DUMONT EC, et al: Effect of antioxidant treatments on nitrate tolerance development in normotensive and hypertensive rats. J Hypertens 18:187-196, 2000
22. VAZIRI ND, DING Y, NI Z: Compensatory up-regulation of nitric oxide synthase isoforms in lead-induced hypertension: reversal by a superoxide dismutase mimetic drug. J Pharmacol Exp Ther 298:679-685, 2001
23. VAZIRI ND, NI Z, OVEISI F, et al: Effect of antioxidant therapy on blood pressure and NO synthase expression in hypertensive rats. Hypertension 36:957-964, 2000
24. WASSMAN S, LAUFS U, STAMENKOVIC D, et al: Raloxifene improves endothelial dysfunction in hypertension by reduced oxidative stress and enhanced nitric oxide production. Circulation 105:2083-2091, 2002
25. NAVA M, QUIROZ Y, VAZIRI ND, et al: Melatonin reduces renal interstitial inflammation and improves hypertension in spontaneously hypertensive rats. Am J Physiol Renal Physiol 284:47-454, 2003
26. GRENDLING KK, SORESCU D, USHIO-FUKAI M: NAD(P)H oxidase: Role in cardiovascular biology and diseases. Circ Res 86:494-501, 2000
27. BABIOR BM: NADPH oxidase: An update. Blood 93:1464-1476, 1999
28. BABIOR BM: The NADPH oxidase of endothelial cells. IUBMB Life 50:267-269, 2000
29. CHABRASHVILI T, TOJO A, ONOZATO ML, et al: Expression and cellular localization of classic NADPH oxidase subunits in the SHR kidney. Hypertension 39:269-274, 2002
30. GEISZT, M, KOPP JB, VARNAI P, et al: Identification of renox, an NAD(P)H oxidase in kidney. Proc Natl Acad Sci USA 97:8010-8014, 2000
31. ZALBA G, SAN JOSE G, Moreno MU, et al: Oxidative stress in arterial hypertension: Role of NAD(P)H oxidase. Hypertension 38:1395-1409, 2001
32. RODRIGUEZ-ITURBE B, QUIROZ Y, NAVA M, et al: Reduction of renal immune cell infiltration results in blood pressure control in genetically hypertensive rats. Am J Physiol Renal Physiol 282:F191-201, 2002
33. RODRÍGUEZ-ITURBE B, ZHAN CD, QUIROZ Y, et al: Antioxidant-rich diet improves hypertension and reduces renal immune infiltration in spontaneously hypertensive rats. Hypertension 41:341-346, 2003
34. RUSNAK F, MERTZ P: Calcineurin: Form and function. Physiol Rev 80:1483-1521, 2000
35. BUEGE JA, AUST SD: Microsomal lipid peroxidation. Methods in Enzymology 52:302-310, 1978
36. GONICK HC, DING Y, BONDY SC, et al: Lead-induced hypertension: Interplay of nitric oxide and reactive oxygen species. Hypertension 30:1487-1492, 1997
37. BAPAT S, POST JA, BRAAM B, et al: Visualizing tubular lipid peroxidation in intact renal tissue in hypertensive rats. J Am Soc Nephrol 13:2990-2996, 2002
38. ZHOU XJ, WANG Q, VAZIRI ND: Association of renal injury with nitric oxide deficiency in aged spontaneously hypertensive rats: prevention by AT-1 receptor blockade. Kidney Int 62:914-921, 2002
39. SATO M, YANAGISAWA H, NOJIMA Y, et al: Zinc deficiency aggravates hypertension in spontaneously hypertensive rats: Possible role of Cu/Zn-superoxide dismutase. Clin Exp Hypertens 24:355-70, 2002
40. REDDI AS, BOLLINENI JS: Selenium-deficient diet induces renal oxidative stress and injury via TGF-B in normal and diabetic rats. Kidney Int 59:1342-1353, 2001
41. ALVAREZ V, QUIROZ Y, NAVA M, et al: Overload proteinuria is followed by salt-sensitive hypertension caused by renal infiltration of immune cells. Am J Physiol Renal Physiol 283(5):F1132-1141, 2002
42. RODRIGUEZ-ITURBE B, PONS H, QUIROZ Y, et al: Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure. Kidney Int 59(6):2222-2232, 2001
43. QUIROZ Y, PONS H, GORDON KL, et al: Mycophenolate mofetil prevents salt-sensitive hypertension resulting from nitric oxide synthesis inhibition. Am J Physiol Renal Physiol 281(1):F38-47, 2001
44. SVENDSEN UG: Evidence for an initial, thymus independent and a chronic, thymus dependent phase of DOCA and salt hypertension in mice. Acta Pathol Microbiol Scand [A] 84(6): 523-528, 1976
45. SCHREIBER SL, CRABTREE GR: The mechanism of action of cyclosporin A and FK506. Immunol Today 13(4):136-142, 1992
46. JAIN J, MCCAFFREY PG, MINER Z, et al: The T-cell transcription factor NFATp is a substrate for calcineurin and interacts with Fos and Jun. Nature 365(6444):352-355, 1993
47. LUO C, BURGEONE, CAREW JA, et al: Recombinant NFAT1 (NFATp) is regulated by calcineurin in T cells and mediates transcription of several cytokine genes. Mol Cell Biol 16(7):3955-3966, 1996
48. BELLET M, CABROL C, SASSANO P, et al: Systemic hypertension after cardiac transplantation: Effect of cyclosporine on the renin-angiotensin- aldosterone system. Am J Cardiol 56:927-931, 1985
49. VAZIRI ND, NI Z, ZHANG YP, et al: Depressed renal and vascular nitric oxide synthase expression in cyclosporine-induced hypertension. Kidney Int 52:482-491, 1998
50. CALO LA, DAVIS PA, GIACON B, et al: Oxidative stress in kidney transplant patients with calcineurin inhibitor-induced hypertension: Effect of ramipril. J Cardiovasc Pharmacol 40:625-631, 2002
51. GALLE J, LEHMANN-BODEM C, HUBNER U, et al: CyA and OxLDL cause endothelial dysfunction in isolated arteries through endothelin-mediated stimulation of O(2)(-) formation. Nephrol Dial Transplant 15:339-346, 2000
52. VAZIRI ND, WONG XQ, KIVLIGHN S, SHAHINFAR S: Effect of aging and AT-1 receptor blockade on nitric oxide. Synthase expression in hypertensive rats. Biochem Biophys ACTA 1592:153-161, 2002